Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors

N. Andres Parra; Hong Lu; Qian Li; Radka Stoyanova; Alan Pollack; Sanoj Punnen; Jung Choi; Mahmoud Abdalah; Christopher Lopez; Kenneth Gage; Jong Y. Park; Yamoah Kosj; Julio M. Pow-Sang; Robert J. Gillies; Yoganand Balagurunathan

doi:10.18632/oncotarget.26802

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Errata:

Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors

PDF | How to cite

Oncotarget. 2019; 10:2113-2113. https://doi.org/10.18632/oncotarget.26802

Metrics: PDF 1572 views | ?

N. Andres Parra¹, Hong Lu^1,2, Qian Li², Radka Stoyanova³, Alan Pollack³, Sanoj Punnen⁴, Jung Choi⁵, Mahmoud Abdalah¹, Christopher Lopez³, Kenneth Gage⁵, Jong Y. Park⁶, Yamoah Kosj^6,7, Julio M. Pow-Sang⁸, Robert J. Gillies^1,5 and Yoganand Balagurunathan¹

¹ Department of Cancer Physiology, H.L. Moffitt Cancer Center, Tampa, FL, USA
² Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
³ Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA
⁴ Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA
⁵ Department of Radiology, H.L. Moffitt Cancer Center, Tampa, FL, USA
⁶ Department of Cancer Epidemiology, H.L. Moffitt Cancer Center, Tampa, FL, USA
⁷ Department of Radiation Oncology, H.L. Moffitt Cancer Center, Tampa, FL, USA
⁸ Department of Urology, H.L. Moffitt Cancer Center, Tampa, FL, USA

Published: March 12, 2019

This article has been corrected: During production, the author name for this article was given incorrectly. The proper author name is shown below.

N. Andres Parra

Original article: Oncotarget. 2018; 9:37125-37136. DOI: https://doi.org/10.18632/oncotarget.26437.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26802

Publication Alerts

Post-Publication Promotion

Publication Discount

Errata:

Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors